Ajanta Pharma’s promoters have sold 27 lakh equity shares or 3.07% stake in the company. Consequent to sale, promoter holding has come down from 73.78% to 70.71% stake in the company. This sale has been done to provide liquidity to the promoters and the proceeds will be utilized for personal use.
Ajanta Pharma is a speciality pharmaceutical formulation company having branded generic business in India and emerging markets, generic business in US and institution business in Africa.